Teladoc Health [TDOC] vs Omnicell [OMCL] Detailed Stock Comparison

Teladoc Health Inc.

NYSE
Loading...

Omnicell Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Teladoc Health Inc. wins in 6 metrics, Omnicell Inc. wins in 12 metrics, with 0 ties. Omnicell Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Teladoc Health Inc. Omnicell Inc. Better
P/E Ratio (TTM) N/A 918.75 N/A
Price-to-Book Ratio 0.74 1.34 Teladoc Health Inc.
Debt-to-Equity Ratio 75.06 16.59 Omnicell Inc.
PEG Ratio -6.16 -8.01 Teladoc Health Inc.
EV/EBITDA 38.86 36.82 Omnicell Inc.
Profit Margin (TTM) -7.92% 0.17% Omnicell Inc.
Operating Margin (TTM) -4.20% 2.20% Omnicell Inc.
EBITDA Margin (TTM) N/A 2.20% N/A
Return on Equity -13.93% 0.17% Omnicell Inc.
Return on Assets (TTM) -3.20% 0.36% Omnicell Inc.
Free Cash Flow (TTM) $137.33M $69.37M Teladoc Health Inc.
1-Year Return 7.00% 29.33% Omnicell Inc.
Price-to-Sales Ratio (TTM) 0.41 1.41 Teladoc Health Inc.
Enterprise Value $1.28B $1.68B Omnicell Inc.
EV/Revenue Ratio 0.51 1.42 Teladoc Health Inc.
Gross Profit Margin (TTM) 69.32% 41.51% Teladoc Health Inc.
Revenue per Share (TTM) $14 $26 Omnicell Inc.
Earnings per Share (Diluted) $-34.20 $0.04 Omnicell Inc.
Beta (Stock Volatility) 2.08 0.86 Omnicell Inc.
Short % of Float 16.55% 6.68% Omnicell Inc.

Teladoc Health Inc. vs Omnicell Inc. Stock Performance Analysis

Loading Price Chart...

TDOC
OMCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Teladoc Health Inc.1.63%5.37%17.30%38.40%1.63%5.82%
Omnicell Inc.5.71%-4.67%-7.26%16.62%-7.58%-11.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Teladoc Health Inc.7.00%-70.52%-95.30%-42.92%-73.79%-73.79%
Omnicell Inc.29.33%-47.23%-73.67%16.01%151.70%181.05%

Performance & Financial Health Analysis: Teladoc Health Inc. vs Omnicell Inc.

MetricTDOCOMCL
Market Information
Market Cap i$1.04B$1.65B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,716,750390,030
90 Day Avg. Volume i4,439,277505,763
Last Close$7.46$39.99
52 Week Range$4.40 - $9.77$26.85 - $55.00
% from 52W High-23.64%-27.29%
All-Time High$308.00 (Feb 15, 2021)$187.29 (Nov 22, 2021)
% from All-Time High-97.58%-78.65%
Growth Metrics
Quarterly Revenue Growth0.00%0.02%
Quarterly Earnings Growth0.00%N/A
Financial Health
Profit Margin (TTM) i-0.08%0.00%
Operating Margin (TTM) i-0.04%0.02%
Return on Equity (TTM) i-0.14%0.00%
Debt to Equity (MRQ) i75.0616.59
Cash & Liquidity
Book Value per Share (MRQ)$7.77$27.36
Cash per Share (MRQ)$4.38$4.33
Operating Cash Flow (TTM) i$294.36M$127.30M
Levered Free Cash Flow (TTM) i$226.14M$94.53M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Teladoc Health Inc. vs Omnicell Inc.

MetricTDOC (Apr 26, 2026)OMCL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A918.75
Forward P/E i-6.1617.60
PEG Ratio i-6.16-8.01
Price to Sales (TTM) i0.411.41
Price to Book (MRQ) i0.741.34
Market Capitalization
Market Capitalization i$1.04B$1.65B
Enterprise Value i$1.28B$1.68B
Enterprise Value Metrics
Enterprise to Revenue i0.511.42
Enterprise to EBITDA i38.8636.82
Risk & Other Metrics
Beta i2.080.86
Book Value per Share (MRQ) i$7.77$27.36

Financial Statements Comparison: Teladoc Health Inc. vs Omnicell Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTDOC (2025)OMCL (2025)
Revenue/Sales i2.53B1.18B
Cost of Goods Sold i771.59M681.40M
COGS % of Revenue i30.5%57.5%
Gross Profit i1.76B503.44M
Gross Margin i69.5%42.5%
Research & Development i277.92M88.67M
Operating Income (EBIT) i-163.40M5.16M
Operating Margin i-6.5%0.4%
EBITDA i260.18M91.79M
EBITDA Margin i10.3%7.7%
Pre-Tax Income i-235.53M11.33M
Pre-Tax Income % of Revenue i-9.3%1.0%
Income Tax i-35.21M9.27M
Income Tax % of Revenue i-1.4%0.8%
Net Income (Profit) i-200.32M2.05M
Profit Margin i-7.9%0.2%

Balance Sheet & Liquidity Metrics

MetricTDOC (2025)OMCL (2025)
Cash & Equivalents i781.08M196.52M
Total Current Assets i1.12B680.07M
Total Current Assets % of Revenue i44.2%57.4%
Total Current Liabilities i404.74M476.61M
Total Current Liabilities % of Revenue i16.0%40.2%
Long-Term Debt i1.03B192.39M
Long-Term Debt % of Revenue i40.7%16.2%
Total Shareholders Equity i1.39B1.23B
Retained Earnings i-16.43B384.94M
Retained Earnings % of Revenue i-649.4%32.5%
Property, Plant & Equipment i42.03M128.44M

Cash Flow Statement Comparison

MetricTDOC (2025)OMCL (2025)
Operating Cash Flow i225.59M155.13M
Operating Cash Flow % of Revenue i8.9%13.1%
Capital Expenditures iN/A-40.42M
Free Cash Flow i137.33M69.37M
FCF Margin i5.4%5.9%
Debt Repayment i-550.63M-175.00M
Common Stock Repurchase iN/A-77.60M

Short Interest & Institutional Ownership Analysis

MetricTDOCOMCL
Shares Short i29.71M2.50M
Short Ratio i6.894.16
Short % of Float i16.55%6.68%
Shares Outstanding i178.32M45.03M
Float Shares i176.23M41.91M
% Held by Insiders i0.65%2.20%
% Held by Institutions i75.86%106.39%
% Held by Public i23.49%-8.59%

Dividend Analysis & Yield Comparison: Teladoc Health Inc. vs Omnicell Inc.

MetricTDOCOMCL
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A